323
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Emerging Prevalence and Clinical Features of Elizabethkingia meningoseptica Infection in Southwest China: A 9-Year Retrospective Study and Systematic Review

ORCID Icon, , , , , , , , , & show all
Pages 531-543 | Received 15 Nov 2022, Accepted 06 Jan 2023, Published online: 25 Jan 2023

References

  • Rahi M, Amoah K, Gunasekaran K, Kapil R, Kwon JS. Elizabethkingia meningoseptica sepsis associated with COVID-19 infection: an emerging nosocomial pathogen. Am J Respir Crit Care Med. 2021;203.
  • Kim KK, Kim MK, Lim JH, Park HY, Lee ST. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov. Int J Syst Evol Microbiol. 2005;55:1287–1293. doi:10.1099/ijs.0.63541-0
  • Balm MND, Salmon S, Jureen R, et al. Bad design, bad practices, bad bugs: frustrations in controlling an outbreak of Elizabethkingia meningoseptica in intensive care units. J Hospital Infection. 2013;85:134–140. doi:10.1016/j.jhin.2013.05.012
  • Chawla K, Gopinathan A, Varma M, Mukhopadhyay C. Elizabethkingia meningoseptica outbreak in intensive care unit. J Glob Infect Dis. 2015;7:43–44. doi:10.4103/0974-777X.150890
  • Agrawal A, Ravikumar R, Varun CN, et al. Global Proteome Profiling Reveals Drug-Resistant Traits in Elizabethkingia meningoseptica: an Opportunistic Nosocomial Pathogen. j Integrative Biol. 2019;23:318–326. doi:10.1089/omi.2019.0039
  • Wadhwa T, Sengupta S, Sarma S, Kaur A, Kumar N, Baveja U. Emergence of Elizabethkingia meningoseptica as a nosocomial pathogen causing outbreaks and lessons learnt in containing the spread in the hospital. Antimicrob Resist Infect Control. 2017;6. doi:10.1186/s13756-016-0149-9
  • Jung SH, Lee B, Mirrakhimov AE, Hussain N. Septic shock caused by Elizabethkingia meningoseptica: a case report and review of literature. BMJ Case Rep. 2013. doi:10.1136/bcr-2013-009066
  • Huang YC, Huang YW, Lin YT, Wang FD, Chan YJ, Yang TC. Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan. Eur J Clin Microbiol Infect Dis. 2017;36:1373–1380. doi:10.1007/s10096-017-2942-7
  • Erinmez M, Buyuktas Manay A, Zer Y. Investigation of an outbreak of Elizabethkingia meningoseptica on a pediatric intensive care unit. GMS Hygiene Infection Control. 2021;16:1548.
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
  • Ann SY, Sung Hyeok Ryou MD, Kim JW. Experience with Elizabethkingia meningoseptica Infection in Adult Patients at a Tertiary Hospital. Acute Critical Care. 2015;30:241–248.
  • Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–281. doi:10.1111/j.1469-0691.2011.03570.x
  • Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13:147–153. doi:10.1097/XEB.0000000000000054
  • Lin YT, Chiu CH, Chan YJ, et al. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan. Scand J Infect Dis. 2009;41:628–634. doi:10.1080/00365540903089476
  • Hsu MS, Liao CH, Huang YT, et al. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006. Eur J Clin Microbiol Infect Dis. 2011;30:1271–1278. doi:10.1007/s10096-011-1223-0
  • Chang YC, Lo HH, Hsieh HY, Chang SM. Identification and epidemiological relatedness of clinical Elizabethkingia meningoseptica isolates from central Taiwan. J Microbiol Immunol Infection. 2014;47:318–323. doi:10.1016/j.jmii.2013.03.007
  • Lin JN, Lai CH, Yang CH, Huang YH. Comparison of Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between Elizabethkingia meningoseptica and Elizabethkingia anophelis Isolated in Taiwan. J Clin Med. 2018;7:6489.
  • Ratnamani M, Rao R. Elizabethkingia meningoseptica: emerging nosocomial pathogen in bedside hemodialysis patients. Indian J Critical Care Med. 2013;17:304–307. doi:10.3205/dgkh000390
  • Rastogi N, Mathur P, Bindra A, et al. Infections due to Elizabethkingia meningoseptica in critically injured trauma patients: a seven-year study. J Hospital Infection. 2016;92:30–32. doi:10.1016/j.jhin.2015.07.008
  • Pindi G, Kale P, Khillan V, Khodhare A. Elizabethkingia meningoseptica: waiting to Strike. J Clin Diagnostic Res. 2019;13:DC16–DC20.
  • Saygılı N, Doğan G. A rare agent; growth of Elizabethkingia Meningoseptica, 11 years of evaluation. Ann Clin Analytical Med. 2021;12:855–859.
  • Issack MI, Neetoo Y. An outbreak of Elizabethkingia meningoseptica neonatal meningitis in Mauritius. J Infect Dev Ctries. 2011;5:834–839. doi:10.3855/jidc.1885
  • Pereira GH, Garcia DDO, Abboud CS, Barbosa VLDB, da Silva PSL. Nosocomial infections caused by Elizabethkingia meningoseptica: an emergent pathogen. Br J Infect Dis. 2013;17:606–609. doi:10.1016/j.bjid.2013.02.011
  • Moore LSP, Owens DS, Jepson A, et al. Waterborne Elizabethkingia meningoseptica in Adult Critical Care. Emerg Infect Dis. 2016;22:9–17. doi:10.3201/eid2201.150139
  • Chan JC, Chong CY, Thoon KC, et al. Invasive paediatric elizabethkingia meningoseptica infections are best treated with a combination of piperacillin/tazobactam and trimethoprim/sulfamethoxazole or fluoroquinolone. J Med Microbiol. 2019;68:1167–1172. doi:10.1099/jmm.0.001021
  • Umair A, Nasir N. Clinical features and outcomes of critically ill patients with Elizabethkingia meningoseptica: an emerging pathogen. Acute Critical Care. 2021;36(3):256–261. doi:10.4266/acc.2020.01158:5
  • Choi MH, Kim M, Jeong SJ, et al. Risk Factors for Elizabethkingia Acquisition and Clinical Characteristics of Patients, South Korea. Emerg Infect Dis. 2019;25:42–51. doi:10.3201/eid2501.171985
  • Balakrishnan S, Sankar P, Shareek PS, Nath J, Pisharody R. Elizabethkingia meningoseptica outbreak in adult hemodialysis unit-outbreak investigation and intervention analysis. Nephrol Dialysis Transplantation. 2017;32:iii672. doi:10.1093/ndt/gfx178.MP653
  • Patro P, Das P, Padhi P. Intrinsically Resistant Bacteria as Looming Disaster: a Rare Case Report of Elizabethkingia meningoseptica Meningitis in a Neonate. J Lab Physicians. 2021;13:70–73. doi:10.1055/s-0041-1724234
  • de-las-Casas-Cámara G, Martín-Ríos MD. Under-utilization of taps in intensive care unit as a cause of reservoirs of nonfermenting gram-negative bacilli. Enferm Infecc Microbiol Clin. 2018;36:214–217. doi:10.1016/j.eimc.2017.01.008
  • Erinmez M, Büyüktas Manay A, Zer Y. Investigation of an outbreak of Elizabethkingia meningoseptica on a pediatric intensive care unit. GMS Hyg Infect Control. 2021;16:358.
  • Huang Y-C, Lin Y-T, Wang F-D. Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia. Int J Antimicrob Agents. 2018;51:47–51. doi:10.1016/j.ijantimicag.2017.05.018